Global Cancer Targeted Drug Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
LPI (LP Information)' newest research report, the “Cancer Targeted Drug Industry Forecast” looks at past sales and reviews total world Cancer Targeted Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Targeted Drug sales for 2023 through 2029. With Cancer Targeted Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Targeted Drug industry.
This Insight Report provides a comprehensive analysis of the global Cancer Targeted Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Targeted Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Targeted Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Targeted Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Targeted Drug.
The global Cancer Targeted Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cancer Targeted Drug players cover Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Targeted Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
LPI (LP Information)' newest research report, the “Cancer Targeted Drug Industry Forecast” looks at past sales and reviews total world Cancer Targeted Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Cancer Targeted Drug sales for 2023 through 2029. With Cancer Targeted Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cancer Targeted Drug industry.
This Insight Report provides a comprehensive analysis of the global Cancer Targeted Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Targeted Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Targeted Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Targeted Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Targeted Drug.
The global Cancer Targeted Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cancer Targeted Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cancer Targeted Drug players cover Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Targeted Drug market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Sorafenib
- Lenvatinib
- Regorafenib
- Osimertinib
- Anlotinib
- Alectinib
- Other
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Eisai
- Zelgen
- Cipla
- Natco Pharma
- AstraZeneca
- Novartis
- Roche
- Bristol-Myers Squibb
- Pfizer
- BEACON Pharma
- Jiangxi Shanxiang
- Yao Pharma
- CSPC
- CHIATAI Tianqing
- Simcere
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Targeted Drug Market Size 2018-2029
2.1.2 Cancer Targeted Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cancer Targeted Drug Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Cancer Targeted Drug Market Size by Type
2.3.1 Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
2.4 Cancer Targeted Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Cancer Targeted Drug Market Size by Application
2.5.1 Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
3 CANCER TARGETED DRUG MARKET SIZE BY PLAYER
3.1 Cancer Targeted Drug Market Size Market Share by Players
3.1.1 Global Cancer Targeted Drug Revenue by Players (2018-2023)
3.1.2 Global Cancer Targeted Drug Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Targeted Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER TARGETED DRUG BY REGIONS
4.1 Cancer Targeted Drug Market Size by Regions (2018-2023)
4.2 Americas Cancer Targeted Drug Market Size Growth (2018-2023)
4.3 APAC Cancer Targeted Drug Market Size Growth (2018-2023)
4.4 Europe Cancer Targeted Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Cancer Targeted Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cancer Targeted Drug Market Size by Country (2018-2023)
5.2 Americas Cancer Targeted Drug Market Size by Type (2018-2023)
5.3 Americas Cancer Targeted Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Targeted Drug Market Size by Region (2018-2023)
6.2 APAC Cancer Targeted Drug Market Size by Type (2018-2023)
6.3 APAC Cancer Targeted Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Targeted Drug by Country (2018-2023)
7.2 Europe Cancer Targeted Drug Market Size by Type (2018-2023)
7.3 Europe Cancer Targeted Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Targeted Drug by Region (2018-2023)
8.2 Middle East & Africa Cancer Targeted Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Cancer Targeted Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER TARGETED DRUG MARKET FORECAST
10.1 Global Cancer Targeted Drug Forecast by Regions (2024-2029)
10.1.1 Global Cancer Targeted Drug Forecast by Regions (2024-2029)
10.1.2 Americas Cancer Targeted Drug Forecast
10.1.3 APAC Cancer Targeted Drug Forecast
10.1.4 Europe Cancer Targeted Drug Forecast
10.1.5 Middle East & Africa Cancer Targeted Drug Forecast
10.2 Americas Cancer Targeted Drug Forecast by Country (2024-2029)
10.2.1 United States Cancer Targeted Drug Market Forecast
10.2.2 Canada Cancer Targeted Drug Market Forecast
10.2.3 Mexico Cancer Targeted Drug Market Forecast
10.2.4 Brazil Cancer Targeted Drug Market Forecast
10.3 APAC Cancer Targeted Drug Forecast by Region (2024-2029)
10.3.1 China Cancer Targeted Drug Market Forecast
10.3.2 Japan Cancer Targeted Drug Market Forecast
10.3.3 Korea Cancer Targeted Drug Market Forecast
10.3.4 Southeast Asia Cancer Targeted Drug Market Forecast
10.3.5 India Cancer Targeted Drug Market Forecast
10.3.6 Australia Cancer Targeted Drug Market Forecast
10.4 Europe Cancer Targeted Drug Forecast by Country (2024-2029)
10.4.1 Germany Cancer Targeted Drug Market Forecast
10.4.2 France Cancer Targeted Drug Market Forecast
10.4.3 UK Cancer Targeted Drug Market Forecast
10.4.4 Italy Cancer Targeted Drug Market Forecast
10.4.5 Russia Cancer Targeted Drug Market Forecast
10.5 Middle East & Africa Cancer Targeted Drug Forecast by Region (2024-2029)
10.5.1 Egypt Cancer Targeted Drug Market Forecast
10.5.2 South Africa Cancer Targeted Drug Market Forecast
10.5.3 Israel Cancer Targeted Drug Market Forecast
10.5.4 Turkey Cancer Targeted Drug Market Forecast
10.5.5 GCC Countries Cancer Targeted Drug Market Forecast
10.6 Global Cancer Targeted Drug Forecast by Type (2024-2029)
10.7 Global Cancer Targeted Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Cancer Targeted Drug Product Offered
11.1.3 Bayer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Cancer Targeted Drug Product Offered
11.2.3 Eisai Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Cancer Targeted Drug Product Offered
11.3.3 Zelgen Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Cancer Targeted Drug Product Offered
11.4.3 Cipla Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Cancer Targeted Drug Product Offered
11.5.3 Natco Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cancer Targeted Drug Product Offered
11.6.3 AstraZeneca Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Cancer Targeted Drug Product Offered
11.7.3 Novartis Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Cancer Targeted Drug Product Offered
11.8.3 Roche Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Cancer Targeted Drug Product Offered
11.9.3 Bristol-Myers Squibb Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Cancer Targeted Drug Product Offered
11.10.3 Pfizer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Cancer Targeted Drug Product Offered
11.11.3 BEACON Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Cancer Targeted Drug Product Offered
11.12.3 Jiangxi Shanxiang Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Cancer Targeted Drug Product Offered
11.13.3 Yao Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Cancer Targeted Drug Product Offered
11.14.3 CSPC Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Cancer Targeted Drug Product Offered
11.15.3 CHIATAI Tianqing Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Cancer Targeted Drug Product Offered
11.16.3 Simcere Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cancer Targeted Drug Market Size 2018-2029
2.1.2 Cancer Targeted Drug Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cancer Targeted Drug Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Cancer Targeted Drug Market Size by Type
2.3.1 Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
2.4 Cancer Targeted Drug Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Cancer Targeted Drug Market Size by Application
2.5.1 Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
3 CANCER TARGETED DRUG MARKET SIZE BY PLAYER
3.1 Cancer Targeted Drug Market Size Market Share by Players
3.1.1 Global Cancer Targeted Drug Revenue by Players (2018-2023)
3.1.2 Global Cancer Targeted Drug Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Targeted Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANCER TARGETED DRUG BY REGIONS
4.1 Cancer Targeted Drug Market Size by Regions (2018-2023)
4.2 Americas Cancer Targeted Drug Market Size Growth (2018-2023)
4.3 APAC Cancer Targeted Drug Market Size Growth (2018-2023)
4.4 Europe Cancer Targeted Drug Market Size Growth (2018-2023)
4.5 Middle East & Africa Cancer Targeted Drug Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cancer Targeted Drug Market Size by Country (2018-2023)
5.2 Americas Cancer Targeted Drug Market Size by Type (2018-2023)
5.3 Americas Cancer Targeted Drug Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Targeted Drug Market Size by Region (2018-2023)
6.2 APAC Cancer Targeted Drug Market Size by Type (2018-2023)
6.3 APAC Cancer Targeted Drug Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cancer Targeted Drug by Country (2018-2023)
7.2 Europe Cancer Targeted Drug Market Size by Type (2018-2023)
7.3 Europe Cancer Targeted Drug Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cancer Targeted Drug by Region (2018-2023)
8.2 Middle East & Africa Cancer Targeted Drug Market Size by Type (2018-2023)
8.3 Middle East & Africa Cancer Targeted Drug Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANCER TARGETED DRUG MARKET FORECAST
10.1 Global Cancer Targeted Drug Forecast by Regions (2024-2029)
10.1.1 Global Cancer Targeted Drug Forecast by Regions (2024-2029)
10.1.2 Americas Cancer Targeted Drug Forecast
10.1.3 APAC Cancer Targeted Drug Forecast
10.1.4 Europe Cancer Targeted Drug Forecast
10.1.5 Middle East & Africa Cancer Targeted Drug Forecast
10.2 Americas Cancer Targeted Drug Forecast by Country (2024-2029)
10.2.1 United States Cancer Targeted Drug Market Forecast
10.2.2 Canada Cancer Targeted Drug Market Forecast
10.2.3 Mexico Cancer Targeted Drug Market Forecast
10.2.4 Brazil Cancer Targeted Drug Market Forecast
10.3 APAC Cancer Targeted Drug Forecast by Region (2024-2029)
10.3.1 China Cancer Targeted Drug Market Forecast
10.3.2 Japan Cancer Targeted Drug Market Forecast
10.3.3 Korea Cancer Targeted Drug Market Forecast
10.3.4 Southeast Asia Cancer Targeted Drug Market Forecast
10.3.5 India Cancer Targeted Drug Market Forecast
10.3.6 Australia Cancer Targeted Drug Market Forecast
10.4 Europe Cancer Targeted Drug Forecast by Country (2024-2029)
10.4.1 Germany Cancer Targeted Drug Market Forecast
10.4.2 France Cancer Targeted Drug Market Forecast
10.4.3 UK Cancer Targeted Drug Market Forecast
10.4.4 Italy Cancer Targeted Drug Market Forecast
10.4.5 Russia Cancer Targeted Drug Market Forecast
10.5 Middle East & Africa Cancer Targeted Drug Forecast by Region (2024-2029)
10.5.1 Egypt Cancer Targeted Drug Market Forecast
10.5.2 South Africa Cancer Targeted Drug Market Forecast
10.5.3 Israel Cancer Targeted Drug Market Forecast
10.5.4 Turkey Cancer Targeted Drug Market Forecast
10.5.5 GCC Countries Cancer Targeted Drug Market Forecast
10.6 Global Cancer Targeted Drug Forecast by Type (2024-2029)
10.7 Global Cancer Targeted Drug Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Cancer Targeted Drug Product Offered
11.1.3 Bayer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Cancer Targeted Drug Product Offered
11.2.3 Eisai Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Cancer Targeted Drug Product Offered
11.3.3 Zelgen Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Cancer Targeted Drug Product Offered
11.4.3 Cipla Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Cancer Targeted Drug Product Offered
11.5.3 Natco Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Cancer Targeted Drug Product Offered
11.6.3 AstraZeneca Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Cancer Targeted Drug Product Offered
11.7.3 Novartis Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Cancer Targeted Drug Product Offered
11.8.3 Roche Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Cancer Targeted Drug Product Offered
11.9.3 Bristol-Myers Squibb Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Cancer Targeted Drug Product Offered
11.10.3 Pfizer Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Cancer Targeted Drug Product Offered
11.11.3 BEACON Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Cancer Targeted Drug Product Offered
11.12.3 Jiangxi Shanxiang Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Cancer Targeted Drug Product Offered
11.13.3 Yao Pharma Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Cancer Targeted Drug Product Offered
11.14.3 CSPC Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Cancer Targeted Drug Product Offered
11.15.3 CHIATAI Tianqing Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Cancer Targeted Drug Product Offered
11.16.3 Simcere Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cancer Targeted Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sorafenib
Table 3. Major Players of Lenvatinib
Table 4. Major Players of Regorafenib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Anlotinib
Table 7. Major Players of Alectinib
Table 8. Major Players of Other
Table 9. Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 12. Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 15. Global Cancer Targeted Drug Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Cancer Targeted Drug Revenue Market Share by Player (2018-2023)
Table 17. Cancer Targeted Drug Key Players Head office and Products Offered
Table 18. Cancer Targeted Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cancer Targeted Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Table 23. Global Cancer Targeted Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Cancer Targeted Drug Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 27. Americas Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 29. Americas Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 31. APAC Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 33. APAC Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 35. APAC Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 37. Europe Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 39. Europe Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 41. Europe Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Cancer Targeted Drug
Table 50. Key Market Challenges & Risks of Cancer Targeted Drug
Table 51. Key Industry Trends of Cancer Targeted Drug
Table 52. Global Cancer Targeted Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Cancer Targeted Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Cancer Targeted Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Cancer Targeted Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Bayer Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 57. Bayer Cancer Targeted Drug Product Offered
Table 58. Bayer Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Eisai Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 62. Eisai Cancer Targeted Drug Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Zelgen Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 67. Zelgen Cancer Targeted Drug Product Offered
Table 68. Zelgen Main Business
Table 69. Zelgen Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Zelgen Latest Developments
Table 71. Cipla Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 72. Cipla Cancer Targeted Drug Product Offered
Table 73. Cipla Main Business
Table 74. Cipla Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cipla Latest Developments
Table 76. Natco Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 77. Natco Pharma Cancer Targeted Drug Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Natco Pharma Latest Developments
Table 81. AstraZeneca Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 82. AstraZeneca Cancer Targeted Drug Product Offered
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. AstraZeneca Latest Developments
Table 86. Novartis Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 87. Novartis Cancer Targeted Drug Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Novartis Latest Developments
Table 91. Roche Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 92. Roche Cancer Targeted Drug Product Offered
Table 93. Roche Main Business
Table 94. Roche Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Cancer Targeted Drug Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 102. Pfizer Cancer Targeted Drug Product Offered
Table 103. Pfizer Main Business
Table 104. Pfizer Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer Latest Developments
Table 106. BEACON Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 107. BEACON Pharma Cancer Targeted Drug Product Offered
Table 108. BEACON Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. BEACON Pharma Main Business
Table 110. BEACON Pharma Latest Developments
Table 111. Jiangxi Shanxiang Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 112. Jiangxi Shanxiang Cancer Targeted Drug Product Offered
Table 113. Jiangxi Shanxiang Main Business
Table 114. Jiangxi Shanxiang Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Jiangxi Shanxiang Latest Developments
Table 116. Yao Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 117. Yao Pharma Cancer Targeted Drug Product Offered
Table 118. Yao Pharma Main Business
Table 119. Yao Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Yao Pharma Latest Developments
Table 121. CSPC Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 122. CSPC Cancer Targeted Drug Product Offered
Table 123. CSPC Main Business
Table 124. CSPC Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. CSPC Latest Developments
Table 126. CHIATAI Tianqing Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 127. CHIATAI Tianqing Cancer Targeted Drug Product Offered
Table 128. CHIATAI Tianqing Main Business
Table 129. CHIATAI Tianqing Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. CHIATAI Tianqing Latest Developments
Table 131. Simcere Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 132. Simcere Cancer Targeted Drug Product Offered
Table 133. Simcere Main Business
Table 134. Simcere Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Simcere Latest Developments
Table 1. Cancer Targeted Drug Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sorafenib
Table 3. Major Players of Lenvatinib
Table 4. Major Players of Regorafenib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Anlotinib
Table 7. Major Players of Alectinib
Table 8. Major Players of Other
Table 9. Cancer Targeted Drug Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 12. Cancer Targeted Drug Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 15. Global Cancer Targeted Drug Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Cancer Targeted Drug Revenue Market Share by Player (2018-2023)
Table 17. Cancer Targeted Drug Key Players Head office and Products Offered
Table 18. Cancer Targeted Drug Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cancer Targeted Drug Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Table 23. Global Cancer Targeted Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Cancer Targeted Drug Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 27. Americas Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 29. Americas Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 31. APAC Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 33. APAC Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 35. APAC Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 37. Europe Cancer Targeted Drug Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Cancer Targeted Drug Market Size Market Share by Country (2018-2023)
Table 39. Europe Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 41. Europe Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Cancer Targeted Drug Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Cancer Targeted Drug Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Cancer Targeted Drug Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Cancer Targeted Drug
Table 50. Key Market Challenges & Risks of Cancer Targeted Drug
Table 51. Key Industry Trends of Cancer Targeted Drug
Table 52. Global Cancer Targeted Drug Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Cancer Targeted Drug Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Cancer Targeted Drug Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Cancer Targeted Drug Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Bayer Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 57. Bayer Cancer Targeted Drug Product Offered
Table 58. Bayer Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Eisai Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 62. Eisai Cancer Targeted Drug Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Zelgen Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 67. Zelgen Cancer Targeted Drug Product Offered
Table 68. Zelgen Main Business
Table 69. Zelgen Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Zelgen Latest Developments
Table 71. Cipla Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 72. Cipla Cancer Targeted Drug Product Offered
Table 73. Cipla Main Business
Table 74. Cipla Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cipla Latest Developments
Table 76. Natco Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 77. Natco Pharma Cancer Targeted Drug Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Natco Pharma Latest Developments
Table 81. AstraZeneca Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 82. AstraZeneca Cancer Targeted Drug Product Offered
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. AstraZeneca Latest Developments
Table 86. Novartis Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 87. Novartis Cancer Targeted Drug Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Novartis Latest Developments
Table 91. Roche Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 92. Roche Cancer Targeted Drug Product Offered
Table 93. Roche Main Business
Table 94. Roche Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Cancer Targeted Drug Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 102. Pfizer Cancer Targeted Drug Product Offered
Table 103. Pfizer Main Business
Table 104. Pfizer Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer Latest Developments
Table 106. BEACON Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 107. BEACON Pharma Cancer Targeted Drug Product Offered
Table 108. BEACON Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. BEACON Pharma Main Business
Table 110. BEACON Pharma Latest Developments
Table 111. Jiangxi Shanxiang Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 112. Jiangxi Shanxiang Cancer Targeted Drug Product Offered
Table 113. Jiangxi Shanxiang Main Business
Table 114. Jiangxi Shanxiang Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Jiangxi Shanxiang Latest Developments
Table 116. Yao Pharma Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 117. Yao Pharma Cancer Targeted Drug Product Offered
Table 118. Yao Pharma Main Business
Table 119. Yao Pharma Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Yao Pharma Latest Developments
Table 121. CSPC Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 122. CSPC Cancer Targeted Drug Product Offered
Table 123. CSPC Main Business
Table 124. CSPC Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. CSPC Latest Developments
Table 126. CHIATAI Tianqing Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 127. CHIATAI Tianqing Cancer Targeted Drug Product Offered
Table 128. CHIATAI Tianqing Main Business
Table 129. CHIATAI Tianqing Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. CHIATAI Tianqing Latest Developments
Table 131. Simcere Details, Company Type, Cancer Targeted Drug Area Served and Its Competitors
Table 132. Simcere Cancer Targeted Drug Product Offered
Table 133. Simcere Main Business
Table 134. Simcere Cancer Targeted Drug Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Simcere Latest Developments
LIST OF FIGURES
Figure 1. Cancer Targeted Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Targeted Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cancer Targeted Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cancer Targeted Drug Sales Market Share by Country/Region (2022)
Figure 8. Cancer Targeted Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 10. Cancer Targeted Drug in Hospital
Figure 11. Global Cancer Targeted Drug Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Cancer Targeted Drug in Retail Pharmacy
Figure 13. Global Cancer Targeted Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Cancer Targeted Drug in Other
Figure 15. Global Cancer Targeted Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 17. Global Cancer Targeted Drug Revenue Market Share by Player in 2022
Figure 18. Global Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cancer Targeted Drug Value Market Share by Country in 2022
Figure 24. United States Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cancer Targeted Drug Market Size Market Share by Region in 2022
Figure 29. APAC Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 30. APAC Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 31. China Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cancer Targeted Drug Market Size Market Share by Country in 2022
Figure 38. Europe Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Cancer Targeted Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cancer Targeted Drug Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cancer Targeted Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cancer Targeted Drug Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cancer Targeted Drug Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cancer Targeted Drug Sales Market Share by Country/Region (2022)
Figure 8. Cancer Targeted Drug Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 10. Cancer Targeted Drug in Hospital
Figure 11. Global Cancer Targeted Drug Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Cancer Targeted Drug in Retail Pharmacy
Figure 13. Global Cancer Targeted Drug Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Cancer Targeted Drug in Other
Figure 15. Global Cancer Targeted Drug Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 17. Global Cancer Targeted Drug Revenue Market Share by Player in 2022
Figure 18. Global Cancer Targeted Drug Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cancer Targeted Drug Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cancer Targeted Drug Value Market Share by Country in 2022
Figure 24. United States Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cancer Targeted Drug Market Size Market Share by Region in 2022
Figure 29. APAC Cancer Targeted Drug Market Size Market Share by Type in 2022
Figure 30. APAC Cancer Targeted Drug Market Size Market Share by Application in 2022
Figure 31. China Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cancer Targeted Drug Market Size Market Share by Country in 2022
Figure 38. Europe Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cancer Targeted Drug Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cancer Targeted Drug Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 57. United States Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 61. China Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 65. India Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 68. France Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 69. UK Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cancer Targeted Drug Market Size 2024-2029 ($ Millions)
Figure 78. Global Cancer Targeted Drug Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cancer Targeted Drug Market Size Market Share Forecast by Application (2024-2029)
